BioSpecifics Technologies Corp

Type: Company
Name: BioSpecifics Technologies Corp
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014

(Date:7/21/2014)... 21, 2014  An International Trade Commission (ITC) ruling ... iCH CPAP device, Taiwanese device manufacturer APEX continues to ... RMD ) is the innovation leader and pioneer ... sleep-disordered breathing. "Our research and development ... [Published Bio-Medicine - Jul 21 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 2 reports

Corporate Updates, Certifications, and Product Launches - Analyst Notes on Analogic, Masimo, Dr. Reddy's, BioSpecifics and Bio-Rad

PR NewswireNEW YORK, July 2, 2014NEW YORKToday, Analysts Review released its analysts' notes regarding Analogic Corporation (NASDAQ: ALOG), Masimo Corporation (NASDAQ: MASI), Dr. Reddy's Laboratories Limited (NYSE: RDY), BioSpecifics Technologies Corp. ... [Published Digital Journal - Jul 02 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 3 reports

BioSpecifics Technologies Corp. to Be Added to Russell 3000® Index

"We are focused on building shareholder value and expect that our inclusion in the Russell Indexes will generate liquidity in our stock through more visibility in the investment community, and by attracting index funds," commented Thomas L. WegmanAnnual ... [Published Industrial Info Financials - Jun 27 2014]
First reported Jun 25 2014 - Updated Jun 26 2014 - 3 reports

BioSpecifics Technologies Corp. Announces Filing by Sobi for EU Approval of XIAPEX for Peyronies Disease

"We have been very encouraged by the progress made on the commercial front by our partner Auxilium for the U.S. launch of XIAFLEX for Peyronie's disease and expect that Peyronie's disease patients in the EU are also eager for an effective and minimally ... [Published Wall Street Select - Jun 25 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 1 reports

InsiderInsights Daily Round Up: 6/23/14

Summary Tables of the top insider purchases and sales filed at the SEC on June 23, 2014, based on dollar value. Dollar values often do not equate with significance when it comes to insider trades. Proprietary Insider Company Ratings are further given ... [Published Seeking Alpha - Jun 24 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

BioSpecifics Technologies Corp. Insider Jeffrey Kenneth Vogel Sells 88,329 Shares (BSTC)

BioSpecifics Technologies Corp. (NASDAQ:BSTC) Insider Jeffrey Kenneth Vogel sold 88,329 shares of BioSpecifics Technologies Corp. stock on the open market in a transaction dated Friday, June 20th. The shares were sold at an average price of $27.43, for ... [Published American Banking News - Jun 23 2014]
First reported May 19 2014 - Updated May 19 2014 - 1 reports

BioSpecifics Announces New Analyses of XIAFLEX for Peyronie's Disease Presented at American Urological Association

LYNBROOK, N.Y., May 19, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: Health - May 19 2014]
First reported May 12 2014 - Updated May 12 2014 - 1 reports

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

LYNBROOK, N.Y., May 12, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced that ... [Published PR Newswire: General Business - May 12 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

BioSpecifics Technologies Corp. Reports First Quarter 2014 Financial Results

LYNBROOK, N.Y., May 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced its financial ... [Published PR Newswire: Health - May 08 2014]
First reported May 01 2014 - Updated May 02 2014 - 1 reports

BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2014 Financial Results on Thursday, May 8, 2014

LYNBROOK, N.Y., May 1, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: Health - May 01 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

BioSpecifics Technologies Corp. to Present at the 13th Annual Needham Healthcare Conference

LYNBROOK, N.Y., April 2, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced that ... [Published PR Newswire: Health - Apr 02 2014]
First reported Feb 19 2014 - Updated Feb 21 2014 - 1 reports

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

LYNBROOK, N.Y., Feb. 19, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced that ... [Published PR Newswire: General Business - Feb 19 2014]

Quotes

"We are focused on building shareholder value and expect that our inclusion in the Russell Indexes will generate liquidity in our stock through more visibility in the investment community, and by attracting index funds" commented Thomas L Wegman
"We have been very encouraged by the progress made on the commercial front by our partner Auxilium for the U S launch of XIAFLEX for Peyronie's disease and expect that Peyronie's disease patients in the EU are also eager for an effective and minimally invasive therapy to treat this physically and psychologically devastating disease" said Thomas L Wegman
"2014 Deep Research Report on Global and China Glutamate Dehydrogenase Industry” is a professional and in-depth research report on China and Global glutamate dehydrogenase market. The report introduces glutamate dehydrogenase basic information, including glutamate dehydrogenase definition, classification, application, and industry chain structure and industry overview. This research covers the international marketmarket analysis, including China’s domestic market as well as global industry analysis covering macroeconomic environment & economic situation analysis, influence of glutamate dehydrogenase industry policy, plans for glutamate dehydrogenase product specification, manufacturing process, product cost structure and more. This report provides statistics on key manufacturers in China and Globally along with their glutamate dehydrogenase capacity production cost, price, profit, production value, gross margin and other information. At the same time, information on these manufacturers also includes customer's application, capacity, market position and company contact information details. China and Global glutamate dehydrogenase 2009-2014 capacity production, price, cost, profit, production value and gross margin information. The report also lists power system upstream raw materials & equipments as well as downstream client’s alternative products, survey analysis, information on marketing channels as well as industry development trends and proposals. Buy a copy of report at http://www.deepresearchreports.com/contacts/purchase.php?name=111611."

More Content

All (23) | News (11) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
BioSpecifics Technologies Corp (NASDAQ: BSTC) t... [Published GlobeNewswire: Advertising News - Jul 22 2014]
Galmed Pharmaceuticals Second Quarter 2014 Conf... [Published Bio-Medicine - Jul 21 2014]
Corporate Updates, Certifications, and Product ... [Published Digital Journal - Jul 02 2014]
Corporate Updates, Certifications, and Product ... [Published PR Newswire: Financial Services - Jul 02 2014]
BioSpecifics Technologies Corp. to Be Added to ... [Published Industrial Info Financials - Jun 27 2014]
BioSpecifics Technologies Corp. to Be Added to ... [Published Staten Island Live - Jun 27 2014]
BioSpecifics Technologies Corp. to Be Added to ... [Published PR Newswire: Health - Jun 27 2014]
BioSpecifics Technologies Corp. Announces Filin... [Published Wall Street Select - Jun 25 2014]
BioSpecifics Technologies Corp. Announces Filin... [Published Barchart - Jun 25 2014]
BioSpecifics Technologies Corp. Announces Filin... [Published PR Newswire: Health - Jun 25 2014]
BIOSPECIFICS TECHNOLOGIES CORP FILES (8-K) Disc... [Published Industrial Info Financials - Jun 24 2014]
InsiderInsights Daily Round Up: 6/23/14 [Published Seeking Alpha - Jun 24 2014]
BioSpecifics Technologies Corp. Insider Jeffrey... [Published American Banking News - Jun 23 2014]
BioSpecifics Announces New Analyses of XIAFLEX ... [Published PR Newswire: Health - May 19 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: General Business - May 12 2014]
Collagenase Industry & Glutamate Dehydrogenase ... [Published PRWeb - May 10 2014]
BioSpecifics Technologies Corp. Reports First Q... [Published PR Newswire: Health - May 08 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - May 01 2014]
BioSpecifics Technologies Corp. to Present at t... [Published PR Newswire: Health - Apr 02 2014]
BioSpecifics Technologies Corp. Reports Fourth ... [Published Financial Services - Mar 06 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - Feb 27 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: General Business - Feb 19 2014]
8-K - BIOSPECIFICS TECHNOLOGIES CORP (000087562... [Published SEC Filings - Nov 22 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Corporate Updates, Certifications, and Product ... [Published PR Newswire: Financial Services - Jul 02 2014]
NEW YORK, July 2, 2014 /PRNewswire/ --Today, Analysts Review released its analysts' notes regarding Analogic Corporation (NASDAQ: ALOG), Masimo Corporation (NASDAQ: MASI), Dr. Reddy's Laboratories Limited (NYSE: RDY), BioSpecifics Technologies Corp. (NASDAQ: ...
BioSpecifics Technologies Corp. to Be Added to ... [Published PR Newswire: Health - Jun 27 2014]
LYNBROOK, N.Y., June 27, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced that effective ...
BioSpecifics Technologies Corp. Announces Filin... [Published PR Newswire: Health - Jun 25 2014]
LYNBROOK, N.Y., June 25, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced today that ...
BioSpecifics Announces New Analyses of XIAFLEX ... [Published PR Newswire: Health - May 19 2014]
LYNBROOK, N.Y., May 19, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: General Business - May 12 2014]
LYNBROOK, N.Y., May 12, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced that ...
1 2

Press Releases

sort by: Date | Relevance
BioSpecifics Technologies Corp (NASDAQ: BSTC) t... [Published GlobeNewswire: Advertising News - Jul 22 2014]
BioSpecifics Technologies Corp. Reports Fourth ... [Published Financial Services - Mar 06 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.